Increasing African Immigrant Women's Participation in Breast Cancer Screening (AIBCS)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04450264 |
Recruitment Status :
Recruiting
First Posted : June 29, 2020
Last Update Posted : August 23, 2022
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Breast Cancer | Behavioral: African Immigrant Breast Cancer Education Program | Not Applicable |

Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 168 participants |
Allocation: | N/A |
Intervention Model: | Single Group Assignment |
Intervention Model Description: | This trial will have a single arm design. All participants will receive the same intervention as the purpose of the current study is to assess feasibility and acceptability of the intervention. The intervention will however, be delivered in English or French (according to language preference of the participant). |
Masking: | None (Open Label) |
Primary Purpose: | Screening |
Official Title: | Increasing African Immigrant's Breast Cancer Screening |
Actual Study Start Date : | February 5, 2020 |
Estimated Primary Completion Date : | June 2023 |
Estimated Study Completion Date : | June 2023 |

Arm | Intervention/treatment |
---|---|
Breast Cancer Education Program |
Behavioral: African Immigrant Breast Cancer Education Program
African immigrant women are at significant risk for not participating in preventive screening, such as for breast cancer. Thus, this project will culturally adapt an existing evidenced-based, the Witness Project, by identifying potential barriers and guided by the Health Belief Model incorporate those findings into a group-based narrative education program for English and French-speaking African immigrant women. The program content will include: (1) information about the benefits of early detection of breast cancer screening, (2) education about disparities in breast cancer, (3) disparities in breast cancer screening among African immigrant women, and (4) will address the unique barriers and facilitators of African immigrant women identified in Aim 1 of this study. The program will use a culturally matched peer approach to educate and model successful experiences with mammography screening. |
- Mammogram intention [ Time Frame: Immediate ]Participants' intentions to complete breast cancer screening by responding to How likely or unlikely is it that you will have a mammogram in the next 12 months? a. Very unlikely b. Unlikely c. Likely d. Very Likely
- Mammogram location and appointment [ Time Frame: Immediate ]Participants' intentions to complete breast cancer screening: Have you thought about where you will have your next mammogram? a. Yes b. No Have you thought about making the appointment? a. Yes b. No
- Perceived Risk [ Time Frame: Immediate ]Participants' perceived risk of developing breast cancer: What do you think are the chances that you will have breast cancer at some point in your life? 1. Very low 2. Somewhat low 3. Moderate 4. Somewhat high 5. Very high
- Comparison Perceived Risk [ Time Frame: Immediate ]Participants' perceived risk of developing breast cancer: Compared to the average person your age and gender, would you say that you are... 1. Less likely to get breast cancer 2. About as likely to get breast cancer 3. More likely to get breast cancer
- Self-Efficacy for Mammography [ Time Frame: Immediate ]Ten items will be used to examine participants' self-efficacy for undergoing mammography using a 5-point Likert-type scale. Full scale from 1 to 5, with higher score indicating greater self-efficacy

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 74 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
AIM 1:
Inclusion Criteria
- ≥ 18 years of age
- Stakeholder/gatekeeper in the African immigrant community, and read and speak English or French.
Exclusion Criteria
- <18 years of age
- Cannot read and speak English or French
AIM 2:
Inclusion Criteria
- ≥ 40 years of age
- Women born in Africa, and read and speak English or French.
Exclusion Criteria
- <40 years of age
- Cannot read and speak English or French

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04450264
Contact: Jamilia R Sly, PhD | 212-824-7813 | jamilia.sly@mssm.edu |
United States, New York | |
Icahn School of Medicine at Mount Sinai | Recruiting |
New York, New York, United States, 10029 | |
Contact: Jamilia R Sly, PhD 212-824-7813 jamila.sly@mssm.edu | |
Principal Investigator: Jamilia R Sly, PhD |
Principal Investigator: | Jamilia R Sly, PhD | Icahn School of Medicine at Mount Sinai |
Responsible Party: | Jamilia Sly, Assistant Professor, Icahn School of Medicine at Mount Sinai |
ClinicalTrials.gov Identifier: | NCT04450264 |
Other Study ID Numbers: |
GCO 17-2188 R21MD012863-01A1 ( U.S. NIH Grant/Contract ) |
First Posted: | June 29, 2020 Key Record Dates |
Last Update Posted: | August 23, 2022 |
Last Verified: | August 2022 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Yes |
Plan Description: | Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices). |
Supporting Materials: |
Study Protocol Statistical Analysis Plan (SAP) Clinical Study Report (CSR) Analytic Code |
Time Frame: | Beginning 3 months and ending 5 years following article publication. |
Access Criteria: | Anyone who wishes to access the data. |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Breast Cancer Screening African Immigrant |
Women New York City French |
Breast Neoplasms Neoplasms by Site Neoplasms Breast Diseases Skin Diseases |